Daily Briefing for October 22, 2026

Epic lets its AI assistants reach into other companies' apps The voices on this episode are generated, and so is the script, from the day's post at Physician in the Loop. Every fact in the post links to its source. Read the post and its sources Get the free email briefing Epic Systems on Oct. 21 introduced Connectors, which link outside developers' apps to its electronic health record so Epic's AI assistants can pull information from those apps and complete tasks in them. Health care organizations can find developer-built Connectors in Epic's Showroom marketplace starting in March 2027 and can review what each one reads and changes before switching it on, the company said. Epic plans to begin testing with some health system partners by the end of 2026 and will charge developers to distribute Connectors, Fierce Healthcare reported . The announcement came at Epic's Open@Epic developer conference, where an Epic executive also said consumer chatbots that pull patient records are adding traffic and cost for health systems. Elsewhere, the American Hospital Association asked the Food and Drug Administration to make AI developers primarily responsible for monitoring generative AI devices, and five large employers backed extending electronic prior authorization to self-funded health plans, the Centers for Medicare & Medicaid Services said. In this episode Epic opens its AI assistants to third-party apps through Connectors, with marketplace listings from March 2027 Consumer chatbots pulling patient records add traffic and cost for Epic customers; Epic adds event alerts to cut repeated data requests Hospital association asks FDA to make developers primarily responsible for monitoring generative AI devices after they are sold Amazon, Google, Meta, Oracle and Axon back extending electronic prior authorization to self-funded employer plans Nebraska Medicine shelves its in-house AI cancer registry tool after it reaches a little over 80% accuracy against a 95% bar FDA clears Elucid's FFR-IQ, which estimates fractional flow reserve from coronary CT angiography using plaque features Doximity adds UpToDate answers to its Ask clinical AI tool for clinicians at health systems that use both products FDA clears NeuroXT's NEXT-Cue, AI software for assessing whether mild cognitive impairment will progress to